Skip to main content
RNTX logo

RNTX

Rein Therapeutics, Inc.
$0.99 +0.01 (+1.38%) At close · Jul 2
Market Cap
$84.81M
Shares
85,539,032

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 46
Total Value: $14,815,488
Total Shares: 11,396,541

Institutional Ownership Trend

14 quarters

Holder Concentration

Across 46 13F filers · Δ vs Dec 31, 2025
Top Holder
38.5%
Jun 2023 → Mar 2026 · range 25.4% – 81.2%
−0.8 pts
Top 5
72.8%
Jun 2023 → Mar 2026 · range 70.8% – 95.6%
−1.7 pts
Top 10
87.0%
Jun 2023 → Mar 2026 · range 87.0% – 99.7%
−1.0 pts
HHI
1,950
Jun 2023 → Mar 2026 · range 1,437 – 6,658
Moderately concentrated−43

Quarterly Activity

vs Dec 31, 2025
New
11
Increased
13
Decreased
5
Sold Out
13
Unchanged
17
Holder count: -2
Institutional value: -16.4%
Shares held: -25.4%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 46 of 46
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1420565 CUSIP 00887A204 Visit website Investor relations